Collaborative Growth Leverage Molecular Devices’ strong Danaher connection and global ecosystem to position bundled solutions that integrate cellular analysis, high-throughput screening, and imaging with partner technologies for faster drug discovery.

Cardio Organoids Explore sales opportunities around the 3D Ready Cardioid Supplement Kit and HeartBeat.bio collaboration to offer physiologically relevant cardiac organoid testing for toxicity and safety assessments.

Automation Expansion Capitalize on ongoing collaborations with Automata and upgrades to automated cell culture systems to upsell AI-ready, end-to-end lab automation platforms across academia and biotech/pharma customers seeking scalable workflows.

Colony & Detection Promote advances in colony picking (QPix FLEX) and microplate detection solutions to pharma and biotech labs aiming to improve throughput, accuracy, and repeatability in screening campaigns.

High-Throughput & Genomics Position Molecular Devices as a one-stop high-throughput, genomic and cellular analysis provider to expand into customers transitioning from legacy systems to integrated, faster discovery platforms, leveraging Danaher’s quality and scale.